NEOGENOMICS INC
For the period ended Dec 31, 2024. Filed Feb 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We operate a network of laboratories. Our leases expire at various dates through 2041. We believe that these locations are sufficient to meet our needs at existing volume levels and, if needed, additional space will be available at a reasonable cost.
We maintain laboratories at all of our facilities, as well as administrative offices at four of our locations. The following table summarizes our facilities by location and approximate square footage:
| Location | Square Footage |
|---|---|
| Fort Myers, Florida | 150,000 |
| Aliso Viejo, California | 112,700 |
| Houston, Texas | 32,800 |
| Durham, North Carolina | 32,100 |
| Carlsbad, California | 28,600 |
| Cambridge, United Kingdom | 12,500 |
| Nashville, Tennessee | 7,800 |
| Tampa, Florida | 5,600 |
| Phoenix, Arizona | 4,700 |
| Atlanta, Georgia | 3,800 |
| Fresno, California | 2,600 |
| Chicago, Illinois | 2,200 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.